{"name":"R-Bio","slug":"r-bio","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"JOINTSTEM","genericName":"JOINTSTEM","slug":"jointstem","indication":"Osteoarthritis of the knee","status":"phase_3"}]}],"pipeline":[{"name":"JOINTSTEM","genericName":"JOINTSTEM","slug":"jointstem","phase":"phase_3","mechanism":"JOINTSTEM is an autologous mesenchymal stem cell therapy that promotes cartilage regeneration and reduces inflammation in damaged joints.","indications":["Osteoarthritis of the knee"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxNSWZaZW4wTV9ZTWlOdkZxSjFUb1BrOTVQcmUzOFU5dUZ2RGM0cFhDVmlZczZWLXRtRTVjZER6WGtwVjhiTjBJS0tyQjduX0o5LTdEbGdhV2wzdVhMcWxRXzhmcnI1OWhjaGQ2YTY1MGUwTnpDNzV3XzFSQUQweU9qcjh2Y25PV3JMV0FfNXJTZERzd19DYXF3UGM0RGRudE5idWNrVFNmTlFWajhlV2JSWmdWWk93Q2QxSlN6UDJwcl9qTzVM?oc=5","date":"2026-02-19","type":"regulatory","source":"BioPharma APAC","summary":"Deciphera Pharmaceuticals Secures FDA NDA Acceptance For Tirabrutinib In R R PCNSL - BioPharma APAC","headline":"Deciphera Pharmaceuticals Secures FDA NDA Acceptance For Tirabrutinib In R R PCNSL","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPOGMwVGVFd3liM28tNnhPbTJmdmYxQ3dRRTZVdWNUeHBzQlhiUzkwUEM3VFQ5NXQ3V2ZwT3BoWUZLN3MwWWpWSlJ5Xzlkd1BneEhuY2RZbzBJOEFoRjhqVnZETTFTMFdGdjRjbTFoZF9id0VGS2toX0E2SWNoZFlETHI5N2xrbjg1RVB4U3NXeUhxay1f?oc=5","date":"2026-02-19","type":"pipeline","source":"Statista","summary":"Total global pharmaceutical R&D spending 2016-2030 - Statista","headline":"Total global pharmaceutical R&D spending 2016-2030","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxQQ2NkSmctSnB4ZnZRZ1hOUnZTVTZaVE9rZDhsSnY3ZmE4QzlvTWd0eWRwcG5GWTVlVFVqSG85NV9idm1NWUE1ajlDcVJ6Vkt4MTlOZlcwNUpQTGFReEdNb2lvS3RaX0tWcTlzcTlaN0xTRWk4Q09GOGVjVkk3d2pSM1o4bzNTTm9LMkVNNE82WGo3eEoyNkJvX056Mkw2N0xzWHdCZ0JxcllUZklxNkJfWmdVNEZmeUE?oc=5","date":"2025-10-28","type":"pipeline","source":"BioPharm International","summary":"AI-Driven Organ-on-Chip Platforms Are Changing the Game in Bio/Pharma R&D - BioPharm International","headline":"AI-Driven Organ-on-Chip Platforms Are Changing the Game in Bio/Pharma R&D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxOR0JKTmVZeEkxRlpGbTlhTFgycGFEQk5nQmVWYkNjRjY1X29mQzluNVBtMEo2MkhxUUxPbWFzN0dvOW9hRGJoV0J0ZUUtci1Hc3R2LXY0UzZENzdzeWM2a3l0Q1p0bk5hT3E4SFBmZGVCdFVub0ZKOGlLUHQtazZSeEQ5QThLTlRyMjl5bXNpSGN4aEcxVkdrVXI4MVFYS2RhNUFDNnlDRHd6NjduT2Nmc3gyR3R5ZDVfei1KUmdlX0F6OFZt?oc=5","date":"2025-09-22","type":"trial","source":"BioPharma APAC","summary":"CorestemChemon Phase 3 ALSummit Trial Shows Subgroup Benefit of Neuronata-R® in ALS - BioPharma APAC","headline":"CorestemChemon Phase 3 ALSummit Trial Shows Subgroup Benefit of Neuronata-R® in ALS","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNMGtGeUxLUXl2Yi1SR0FQWnp0WlZ3MUsxNVBEVXFieGxhQTlqTXdGUjFueUhsWUpub21qbjlyUk1ZVDN3OHROSGczR3Zyb29CQ1hqN0RFczZXVThXOXFkRl9jaXVnRS1fV2lpTmNmUkJlNGNNc0hiMjM2WjVvSHBub0hSa2FQWUVIT0R0U0lIOEFIZXAxTnY5TQ?oc=5","date":"2025-08-19","type":"regulatory","source":"Yahoo Finance","summary":"Belhaven Biopharma Closes Oversubscribed Series a to Fund the Development of Nasdepi(R) Program Moves Into Late Stage Clinical and Manufacturing Through NDA Approval - Yahoo Finance","headline":"Belhaven Biopharma Closes Oversubscribed Series a to Fund the Development of Nasdepi(R) Program Moves Into Late Stage Cl","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxObTBkNTk0LWZqclpDSUpfXzV0Tndva2FpSzhBYThUYUtvLTI3WlczdUdWYlh1SnZiTzRsaDQySmJMM3JySlpXdl9GMGo1YVluNUVRSDBSZl8xcGZPSFJZZ2laeTJlVW91bXNwUUVRcGkwTWlhdVc1MkZYUFIzTEhKVHhfSEc5RjVyUU9xVWwwS2w4c05pTXp2a3BoQk9JS3ZyNC12MGt1TmtkMkttRU0wSDNzVUNpaDJEZW9uOHNCOThmVF9jejZOYUp3ZWpKeEJRNFpQR3JSUThwamRKMUFRbGtFS3dfY1BWem1JUzIwdw?oc=5","date":"2025-05-17","type":"trial","source":"CRISPR Medicine News","summary":"Press Release Service: Be Biopharma Announces New Preclinical Data for BE-102, a B Cell Medicine for the Potential Treatment of Hypophosphatasia - CRISPR Medicine News","headline":"Press Release Service: Be Biopharma Announces New Preclinical Data for BE-102, a B Cell Medicine for the Potential Treat","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxOeUtRd19mbEF0bk55V2xqYlM1UEprd25lR042aFFDX0k0MWV1WjNrb0RCV1lYY0xwXzJJMFZXNDhMZ2owdHN2Z2UwcVl0bkNsSlBIWHVfZXVmNnVMS3NzeHdmelZmd1N0a2dnREZWR1BOS29SNzZfU1R6UEo2b0xQS2Y2WjExcmxMWFFLeXp5RHVEeWZSWkFvTEdRakt4b0RlUGJrTA?oc=5","date":"2025-04-10","type":"regulatory","source":"BioPharma Dive","summary":"Biotech CEOs, VCs urge Cassidy, Senate to ease impact of FDA cuts - BioPharma Dive","headline":"Biotech CEOs, VCs urge Cassidy, Senate to ease impact of FDA cuts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxQc3ZxcXZRbWlUODZKZUVxWFB6VzZHQWJla0VHaVk2MGZES2p0ZDFTX21uT0s5SFJoNnpZVzMwRXhKTUFVcDhqMDE2MVhtblR0Uk14bHB6QXlXUHRPNFRRRGVRc2ZuMVVqUURKSmMxYkhLeWZJVUxhWTFLMzc2ZFdLVTBOMWl3UEtUQWV4SHdzM3dfYl9ITmhvX1dDcmJHMUVPZ1VqTzFHa0lBWDVIRmV0M3otZw?oc=5","date":"2025-03-26","type":"pipeline","source":"IQVIA","summary":"Global Trends in R&D 2025 - IQVIA","headline":"Global Trends in R&D 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxPT2I3dkh2NV9iMDBYTVBWcVFJb1Q4X28zVjlVSnBZeWN6MmZRTmFXSDFkVmJIYkhTU05sdmxiNmxRWVpuTGJ0aXU0ak5idGF0V3hOc2hmTmdYMWxoT2dmb0J1cjZybjJDVDEycjhjRUU3aE5tZ2Y3amdjTVNWQjlRUkd4TTU2WTNrbUdhaWxtT2k4M0M2dEh2WDlHUEtzMDB0Y0JUa2FlcElIQXRnSTNjOThBdVREQjVGaXF6MDN0anN2amVDNnVoQzdUMGZpUQ?oc=5","date":"2025-01-09","type":"deal","source":"McKinsey & Company","summary":"External innovation: Biopharma dealmaking to boost R&D productivity - McKinsey & Company","headline":"External innovation: Biopharma dealmaking to boost R&D productivity - McKinsey & Company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxQcU9rbjI2akd2NDFWNjdVOGEwOEpIZExiVk9ocVd5aEM1T3Z4NElqdmdRUDlIQUd0dlBMVGhiVVFIMG04enBjT0x4cG5SMHpUYzluZHh6LU54UzJqdVZqNXBDRnF1d2VGeXRYcWdIZklnOHJsUWVvUFRfZVdNVmNmZkFFeWd6RWhIRHlBa09GQVd1WTN1cGN4U0NQeXJ4OVZZYkQ3dUNhUzFoV0hhNGcwTHVpblV0bnBJY0pIc01QNkt2WlZYdndUTENjT2dYUQ?oc=5","date":"2024-01-22","type":"trial","source":"McKinsey & Company","summary":"Accelerating clinical trials to improve biopharma R&D productivity - McKinsey & Company","headline":"Accelerating clinical trials to improve biopharma R&D productivity - McKinsey & Company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgJBVV95cUxNRk4zZERJaEV1VzNJeC1ram9rWGRqeTRXejhnamtxamZmQ0pvSThyQVlfcVY3YTB4c3Bkd0o4RXFjMzhhbTlPRVJkQW0xcm5OaEdvcXdSaDZmNS15TDlmRFA5MzE2RGtIXzVVU0FCOTE4Q1E2TW5PblpsQ0dCaWk3YTlQNTlUR3hCUlNLdjd4SXhKRW13MWlFN0ExTVdMSVpibjk4aGhaeGdQbkt3NGNXX2Zwb1hJWEZ3V1FjSHZfby0zVndGOE9yMUx0TnpBcW8yYzg0Q1VGYnMzajgxZVM4WkEwSGM1UU5kMkcycllMQkdLMUhJc01HZHZMY3BkTjV1b2w5aXMyeHA5b3IydDZGRWdIeDZaVjR0bnFZeHQ4OTNnMVptX0E?oc=5","date":"2022-07-19","type":"pipeline","source":"Via Ritzau","summary":"R-Biopharm starts commercialization of the fully automated RIDA®UNITY system for real-time PCR in molecular diagnostic laboratories - Via Ritzau","headline":"R-Biopharm starts commercialization of the fully automated RIDA®UNITY system for real-time PCR in molecular diagnostic l","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNbFhmY0F1MWJnVy1ndzJkTFFDM0VQM0pHY1BSLTY0dHpXOWxibG52QjA1VGJjd2tHbmd2bUR2RTNPLVRYUGdhRkxHMXBJeUQtNGRTWnJZTTBNS1A5ZVhRMGxJWEoxQTVvUjV2VzB6dllaWEJWTUZpRGxtZU9KYXY5dVZ1WU9TMnNKUkxscU1rdVdUNmoweW4zbUx0WjNjQQ?oc=5","date":"2016-03-22","type":"deal","source":"Genetic Engineering and Biotechnology News","summary":"R-Biopharm, Merck KGaA Launch Companion Diagnostics Collaboration - Genetic Engineering and Biotechnology News","headline":"R-Biopharm, Merck KGaA Launch Companion Diagnostics Collaboration","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}